Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Sales | 3,554 | 6,002 | 0 | 0 | 0 |
| Gross Profit | 3,554 | 6,002 | N/A | N/A | N/A |
| Operating Expenses | 20,804 | 13,906 | 9,812 | 4,870 | 0 |
| Operating Income | -17,250 | -7,903 | -9,812 | -4,870 | N/A |
| Other Income | 1,649 | 639 | -2,433 | -22 | 0 |
| Pre-tax Income | -15,601 | -7,264 | -12,245 | -4,892 | 0 |
| Income Tax | -720 | 724 | N/A | N/A | N/A |
| Net Income Continuous | -14,881 | -7,988 | -12,245 | -4,892 | N/A |
| Net Income | $-14,881 | $-7,988 | $-12,245 | $-4,892 | $N/A |
| EPS Basic Total Ops | -0.98 | -0.79 | -4.73 | -1.89 | N/A |
| EPS Basic Continuous Ops | -0.98 | -0.79 | -4.73 | -1.89 | N/A |
| EPS Diluted Total Ops | -0.98 | -0.79 | -4.73 | -1.89 | N/A |
| EPS Diluted Continuous Ops | -0.98 | -0.79 | -4.73 | -1.89 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.98 | -0.79 | -4.73 | -1.89 | N/A |
| EBITDA(a) | $-17,222 | $-7,876 | $-9,785 | $-4,854 | $N/A |